top of page

Sources

Material sources are listed below.

 

Herd Immunity Handout April 2025 MVC.png

April 2025
Herd Immunity: Do Vaccine Products Deliver?

  1. Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines - Cox - 2004 - Scandinavian Journal of Immunology
    https://onlinelibrary.wiley.com/doi/full/10.1111/j.0300-9475.2004.01382.x

     

  2. Influenza vaccine effectiveness in the community and the household
    https://europepmc.org/article/PMC/3693492

     

  3. Increased Risk of Noninfluenza Respiratory Virus Infections Associated with Receipt of Inactivated Influenza Vaccine
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3404712
    ​

  4. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
    https://www.ncbi.nlm.nih.gov/pubmed/24277828
    ​

  5. CDC: About Tetanus
    https://www.cdc.gov/tetanus/about/index.html

     

  6. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge
    ​
    https://www.ncbi.nlm.nih.gov/pubmed/22532797

    ​

  7. Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba
    https://www.nejm.org/doi/full/10.1056/NEJMoa054960

     

  8. ​Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak
    https://www.nejm.org/doi/full/10.1056/NEJMoa1703309
    ​

  9. Environmental factors potentially associated with mumps transmission in yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010
    https://www.ncbi.nlm.nih.gov/pubmed/23442590

     

  10. Scientists Sue Merck Alleging MMR Vaccine Efficacy Fraud
    https://ahrp.org/former-merck-scientists-sue-merck-alleging-mmr-vaccine-efficacy-fraud

    ​​

  11. Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among re-vaccinees
    https://www.ncbi.nlm.nih.gov/pubmed/9850133
    ​

  12. The future of measles in highly immunized populations, a modeling approach
    https://academic.oup.com/aje/article-abstract/120/1/39/98627
    ​

     

  13. The Re-Emergence of Measles in Developed Countries: Time to Develop the Next-Generation Measles Vaccines? 
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3905323

     

  14. Junk Science Week: Vaccinating the 'herd'
    http://business.financialpost.com/fp-comment/junk-science-week-vaccinating-the-herd
    ​

  15. Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930734

     

  16. Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities with Contrasting Vaccination Coverage
    https://academic.oup.com/jid/article-abstract/208/1/10/796786?redirectedFrom=fulltext

     

  17. Scientists pinpoint mutations responsible for ineffectiveness of 2014-2015 flu vaccine
    https://www.sciencedaily.com/releases/2015/06/150625130251.htm

    ​

  18. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North America outbreak
    http://www.ncbi.nlm.nih.gov/pubmed/22423127
    ​

  19. 2013 Measles Outbreak: A failing vaccine, not a Failure to vaccinate
    https://greenmedinfo.com/blog/2013-measles-outbreak-failing-vaccine-not-failure-vaccinate1

     

  20. Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons
    http://www.ncbi.nlm.nih.gov/pubmed/8053748
    ​

  21. Tdap Vaccine Effectiveness in Adolescents During the 2012 Washington State Pertussis Epidemic
    https://publications.aap.org/pediatrics/article-abstract/135/6/981/75791/Tdap-Vaccine-Effectiveness-in-Adolescents-During

     

  22. Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930734
    ​

  23. Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage
    https://academic.oup.com/jid/article-abstract/208/1/10/796786

     

  24. Scientists pinpoint mutations responsible for ineffectiveness of 2014-2015 flu vaccine
    https://www.sciencedaily.com/releases/2015/06/150625130251.htm

     

  25. Tdap Vaccine Effectiveness in Adolescents During the 2012 Washington State Pertussis Epidemic
    https://publications.aap.org/pediatrics/article-abstract/135/6/981/75791/Tdap-Vaccine-Effectiveness-in-Adolescents-During

     

  26. ​Influenza vaccine effectiveness in the community and the household
    https://pubmed.ncbi.nlm.nih.gov/23413420

     

  27. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine
    https://pubmed.ncbi.nlm.nih.gov/22423139

     

  28. ​Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada
    https://pubmed.ncbi.nlm.nih.gov/20386731

     

  29. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus
    https://pubmed.ncbi.nlm.nih.gov/19538996

    ​

  30. Comparison of VAERS fetal-loss reports during three consecutive influenza seasons
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3888271

     

  31. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
    https://pubmed.ncbi.nlm.nih.gov/24277828

     

  32. ​Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population
    https://pubmed.ncbi.nlm.nih.gov/2278542

    ​

  33. CDC: Causes of Tetanus and How It Spreads
    https://www.cdc.gov/tetanus/causes/index.html

     

  34. ​Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
    https://pubmed.ncbi.nlm.nih.gov/24277828

     

  35. ​Vaccine waning and mumps re-emergence in the United States https://pmc.ncbi.nlm.nih.gov/articles/PMC5899613
     

  36. Former Merck Scientists Sue Merck Alleging MMR Vaccine Efficacy Fraud – Alliance for Human Research Protection
    https://ahrp.org/former-merck-scientists-sue-merck-alleging-mmr-vaccine-efficacy-fraud/

     

  37. Civil Action No. 10-4374, Relators Stephen A. Krahling and Joan A. Wlochowski (“Plaintiffs”) bring this qui tam action in accordance with the False Claims Act (“FCA”), pursuant to 31 U.S.C. §§ 3729-33.  Relators allege that their former employer, Defendant Merck & Co., Inc. (“Merck”) fraudulently misled the government and omitted, concealed, and adulterated material information regarding the efficacy of its mumps vaccine in violation of the FCA. 
    https://www.rescuepost.com/files/59-opinion.pdf

     

  38. Merck Has Some Explaining To Do Over Its MMR Vaccine Claims
    https://www.huffpost.com/archive/ca/entry/merck-has-some-explaining-to-do-over-its-mmr-vaccine-claims_b_5881914

     

  39. ​The Re-Emergence of Measles in Developed Countries: Time to Develop the Next-Generation Measles Vaccines?
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3905323

     

  40. CDC: ​About Hepatitis B
    https://www.cdc.gov/hepatitis-b/about/index.html

     

  41. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community
    https://www.pnas.org/doi/10.1073/pnas.1716561115

     

  42. Loss of Vaccine-Induced Immunity to Varicella over Time
    https://www.nejm.org/doi/full/10.1056/nejmoa064040

     

  43. Successes and Challenges in Varicella Vaccine
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3991154

     

  44. ​Vaccine Types according to HHS.gov
    https://www.hhs.gov/immunization/basics/types/index.html

COVID - WYNTK.PNG

May 2021
COVID - What You Need To Know

  1. Doshi P. Will covid-19 vaccines save lives? Current trials aren’t designed to tell us. BMJ. 2020;371:m4037.
    https:// www.bmj.com/content/371/bmj.m4037

     

  2. Haseltine WA. Covid-19 vaccine protocols reveal that trials are designed to suc- ceed. Forbes, September 23, 2020. 
    https://www.forbes.com/sites/williamhasel- tine/2020/09/23/covid-19-vaccine-protocols-reveal-that-trials-are- designed-to-suc- ceed/?sh=5da0663d5247

     

  3. Brownstein D, Ng R, Rowen R et al. A novel approach to treating COVID-19 using nutritional and oxidative therapies. Science, Public Health Policy, and the Law 2020;2:4-22.
    https://ozonewithoutborders.ngo/wp-content/ uploads/2020/07/Novel-Approach-to- Covid-19.pdf

     

  4. Jackson LA, Anderson EJ, Rouphael NG et al. An mRNA vaccine against SARS-CoV-2 – preliminary report. New England Journal of Medicine. 2020;383(20):1920-1931
    https://www.nejm.org/doi/full/10.1056/NEJMoa2022483

     

  5. Allen A, Szabo L. NIH “very concerned” about serious side effect in coronavirus vaccine trial. Scientific American, September 15, 2020.
    https://www.scientificamerican.com/ article/nih-very-concerned-about-serious-side-effect-in- coronavirus-vaccine-trial

     

  6. Mayer A. Leading COVID vaccine candidates plagued by safety concerns. The Defender, November 13, 2020
    https://childrenshealthdefense.org/defender/covid-vaccine-can- didates-safety-concerns

     

  7. U.S. Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee, October 22, 2020 Meeting Presentation, slide #16
    https://www.green- medinfo.com/blog/covid-19-vaccine-bombshell-fda- documents-reveal-death-21-seri- ous-conditions-possi1

     

  8. Reals T. U.K. warns against giving Pfizer vaccine to people prone to severe allergic reactions. CBS News, December 9, 2020
    https://www.cbsnews.com/amp/news/ covid-vaccine-pfizer-shot-uk-warning-people-with- history-of-significant-allergic-reactions

     

  9. https://www.fda.gov/media/144245/download   page 42
     

  10. Public Readiness and Emergency Preparedness Act. COVID-19 PREP Act Declarations
    https://www.phe.gov/Preparedness/legal/prepact/Pages/default.aspx

     

  11. Lyons-Weiler J. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. Journal of Translational Autoimmunity.
    2020;3:100051

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142689

     

  12. Khemlani A. Fauci: Early COVID-19 vaccines will only prevent symptoms, not block the virus. Yahoo! Finance, October 26, 2020
    https://finance.yahoo.com/news/fauci-vaccines-will-only-prevent-symptoms-not-block-the-virus-195051568.html

     

  13. Scipioni J. Dr. Fauci says masks, social distancing will still be needed after a Covid-19 vaccine—here’s why. CNBC, November 16, 2020
    https://www.cnbc.com/2020/11/16/ fauci-why-still-need-masks-social-distancing-after-covid-19-vaccine.html

     

  14. Centers for Disease Control and Prevention. COVID-19 pandemic planning scenarios. Updated September 10, 2020
    https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html

     

  15. Petition/motion for administrative/regulatory action regarding confirmation of efficacy end points and use of data in connection with the following clinical trials. Dr. Wolfgang Wodarg and Dr. Michael Yeadon, petitioners. Filed with European Medicines Agency, December 1, 2020
    https://healthimpactnews.com/wp- content/uploads/ sites/2/2020/12/Wodarg_Yeadon_EMA_Petition_Pfizer_Trial_FINAL_01DEC2020_ EN_unsigned_with_Exhibits.pdf

     

  16. AMA, Ethics, Informed Consent 
    https://www.ama-assn.org/delivering-care/ethics/informed-consent

     

  17. Int J Clin Pract. 2020 Oct 28 : e13795., PDF 
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645850/pdf/IJCP-9999-e13795.pdf

     

  18. Front. Microbiol., 05 December 2018 
    https://www.frontiersin.org/articles/10.3389/fmicb.2018.02991/full

     

  19. PNAS.org April 14, 2020 117 (15) 8218-8221 
    https://www.pnas.org/content/117/15/8218

     

  20. JCI Insight February 21, 2019 
    https://insight.jci.org/articles/view/123158

Schedule-2019-PostCard1.PNG
Schedule-2019-PostCard2.PNG

August 2019

Vaccine Schedule Comparison Post Card

Before you go...

Writing on a Notebook

Check Out Our Vaccine Research Resources 

Doctor's Appointment

Find Providers in Support of Vaccine Choice

Vaccinating A Child

NVIC's Ask 8 Before Your Vaccinate

3D Scans

How to Report a Vaccine Injury

Connect with MVC Partners

Former Feds Group Freedom Foundation logo.png
VITA.png
  • Rumble logo
  • Instagram - White Circle
  • X formally Twitter white icon
  • Facebook
  • YouTube - White Circle

©2025 All rights reserved.

 

Michigan for Vaccine Choice (MVC) is a 501(c)(3) organization dedicated to providing educational information about the subject of vaccinations, while protecting and supporting individuals and parents to make vaccine decisions in Michigan.

​

​This website and all materials are for educational purposes only. The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical or legal advice. 

​

Tax ID: 47-5401416

Privacy       Sources       Terms      Volunteers

Our members, volunteers, and donors are the fuel that power this organization. We can use free survey templates to constantly keep in touch with them, understand their expectations and work towards their satisfaction with this simple yet robust tool.

bottom of page